other specialized sustainable alternatives (due to low-cost input and scalability), meaning greater accessibility. (2) Consumer: The ALT TEX fabric is projected to be half the price vs. (1) Fashion brands: ALT TEX sells fabric to fashion brands, allowing them to differentiate via sustainable options (sustainable fashion growing 11% CAGR) and hit sustainability targets, without sacrificing performance or changing their current supply chain. The product solves key problems for fashion brands, consumers, and the environment: The patent-pending ALT TEX fermentation technology creates a polyester alternative that works with the existing infrastructure to supply a sustainable, high performance and cost competitive polyester replacement to fashion brands, at scale. Polyester alone makes up 60% of the $2.5 trillion fashion industry and is the biggest blocker preventing brands from meeting sustainability mandates. In short, Y-Combinator was only the beginning.ĪLT TEX is a Toronto-based biomaterials startup that has developed the world’s first biodegradable and carbon neutral fabric, engineered from the world’s largest landfill contributor - food waste. AesculaTech was named a Rosenman Innovator, received a National Science Foundation I-Corps grant, was a finalist in the 2019 Octane High Tech Awards, and is a graduate of both the Y Combinator and TMCx accelerator programs.

In coordination with partners across several sectors, we have a variety of groundbreaking technologies in the works that live up to our vision.

Though Humidifeye is not yet FDA approved, expect to hear about it soon! In contrast to existing technologies, our product will not extrude, or cause discomfort as it adapts to patients. Our thermally responsive, form-fitting materials are suitable for sustained yet reversible occlusion across a range of treatment times. Dry eye affects more than 25 million Americans and the global treatment market is projected higher than $6 Billion within the next decade. Our cornerstone product, Humidifeye, is an ophthalmic platform to treat dry eye disease.

Our platform technology, AesculaGel offers adaptive response to a wide range of stimuli and can be tailor-made for biocompatibility, material strength, and a range of other attributes.įounded by one of MIT's 35 under 35 Innovators, AesculaTech is the shared vision of scientists, engineers, and medical experts. We design custom smart materials for a range of biomedical, commercial, and industrial applications. AesculaTech believes in building better lives through smart chemistry.

Poko discovery kids ja